SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

UBS Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $165

UBS maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and lowers the price target from $180 to $165.

Benzinga · 05/12/2020 16:37

UBS maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and lowers the price target from $180 to $165.